Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Understanding interactions occurring at the interface between nanoparticles and biological components is an urgent challenge in nanomedicine due to their effect on the biological fate of nanoparticles. After the systemic injection of nanoparticles, a protein corona constructed by blood components surrounds the carrier's surface and modulates its pharmacokinetics and biodistribution. Biomimicry-based approaches in nanotechnology attempt to imitate what happens in nature in order to transfer specific natural functionalities to synthetic nanoparticles. Several biomimetic formulations have been developed, showing superior in vivo features as a result of their cell-like identity. We have recently designed biomimetic liposomes, called leukosomes, which recapitulate the ability of leukocytes to target inflamed endothelium and escape clearance by the immune system. To gain insight into the properties of leukosomes, we decided to investigate their protein corona in vivo. So far, most information about the protein corona has been obtained using in vitro experiments, which have been shown to minimally reproduce in vivo phenomena. Here we directly show a time-dependent quantitative and qualitative analysis of the protein corona adsorbed in vivo on leukosomes and control liposomes. We observed that leukosomes absorb fewer proteins than liposomes, and we identified a group of proteins specifically adsorbed on leukosomes. Moreover, we hypothesize that the presence of macrophage receptors on leukosomes' surface neutralizes their protein corona-meditated uptake by immune cells. This work unveils the protein corona of a biomimetic carrier and is one of the few studies on the corona performed in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“these strategies are still limited at conferring targeting specificity since an additional targeting ligand increases the propensity for protein corona formation to mask the targeting ability and inhibit the biological effects of nanoparticles18–24.”
From Cloaking nanoparticles with protein corona shield for targeted drug delivery. (2018) · cites this paper as [20]
In the citing paper
“suggesting that PCSN can increase their circulation time in the blood by decreasing the uptake from the immune system20.”
From Cloaking nanoparticles with protein corona shield for targeted drug delivery. (2018) · cites this paper as [20]
In the citing paper
“A critical but underexplored determinant of LNP biodistribution is the protein corona, the dynamic layer of plasma proteins adsorbed onto nanoparticle surfaces upon entry into the bloodstream, which fundamentally dictates receptor interactions, cellular uptake pathways, and organ-level distribution [20][21][22] .”
From High-density Lipoprotein Inspired Lipid Nanoparticles for Systemic RNA delivery to the Brain (2026) · cites this paper as [20]
Citations
Cites
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Harrison’s Principles of Internal Medicine
Malani, P. N. (2012) · JAMA · doi:10.1001/jama.308.17.1813-b · Cited by 2,039
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2084338 · Cited by 1,926
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Research works printed but not linked: 2
- Langer R., 1998, Nature, 392, 5
- Lee H., 1985, J. Nucl. Med., 26, 72
Cited by
Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 671
Cloaking nanoparticles with protein corona shield for targeted drug delivery.
Oh, J. Y., Kim, H. S., Palanikumar, L., Go, E. M., Jana, B., Park, S. A., Kim, H. Y., Kim, K., Seo, J. K., Kwak, S. K., et al. (2018) · Nature communications · doi:10.1038/s41467-018-06979-4 · Cited by 409
Rampado, R., Crotti, S., Caliceti, P., Pucciarelli, S., & Agostini, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00166 · Cited by 390
Ban, Z., Yuan, P., Yu, F., Peng, T., Zhou, Q., & Hu, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919755117 · Cited by 313
“Unlike experiments alone (25, 27), a combination of integrated machine learning and experimentation supported the notion that corona functional compositions play a dominant role in mediating biomolecular recognition of NP – corona complexes (3, 39).”
BackgroundCell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery
Wang, H., Liu, Y., He, R., Xu, D., Zang, J., Weeranoppanant, N., Dong, H., & Li, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01392j · Cited by 297
Park, S. J. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254808 · Cited by 293
Liposome and immune system interplay: Challenges and potentials
Zahednezhad, F., Saadat, M., Valizadeh, H., Zakeri-Milani, P., & Baradaran, B. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.030 · Cited by 267
Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery
Parodi, A., Molinaro, R., Sushnitha, M., Evangelopoulos, M., Martinez, J. O., Arrighetti, N., Corbo, C., & Tasciotti, E. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.020 · Cited by 266
Self-citationThe effects of protein corona on in vivo fate of nanocarriers
Xiao, Q., Zoulikha, M., Qiu, M., Teng, C., Lin, C., Li, X., Sallam, M. A., Xu, Q., & He, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114356 · Cited by 255
Recent Advances of Cell Membrane‐Coated Nanomaterials for Biomedical Applications
Liu, W., Zou, M., Qin, S., Cheng, Y., Ma, Y., Sun, Y., & Zhang, X. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003559 · Cited by 225
Belhadj, Z., He, B., Deng, H., Song, S., Zhang, H., Wang, X., Dai, W., & Zhang, Q. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1806444 · Cited by 206
“However, this strategy is rather limited because the ligand modified on the surface of nanoparticles could be screened by the formed protein corona, which masks the targeting capability and influences the biological effects of nanoparticles [78,79].”
BackgroundRapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation
Boada, C., Zinger, A., Tsao, C., Zhao, P., Martinez, J. O., Hartman, K., Naoi, T., Sukhovershin, R., Sushnitha, M., Molinaro, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315185 · Cited by 186
Self-citationSystematic design of cell membrane coating to improve tumor targeting of nanoparticles
Liu, L., Pan, D., Chen, S., Martikainen, M.-V., Kårlund, A., Ke, J., Pulkkinen, H., Ruhanen, H., Roponen, M., Käkelä, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33889-3 · Cited by 175
Understanding the Chemical Nature of Nanoparticle–Protein Interactions
Baimanov, D., Cai, R., & Chen, C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00348 · Cited by 165
Stepien, G., Moros, M., Pérez-Hernández, M., Monge, M., Gutiérrez, L., Fratila, R. M., las Heras, M. D., Menao Guillén, S., Puente Lanzarote, J. J., Solans, C., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18648 · Cited by 158
Membrane engineering of cell membrane biomimetic nanoparticles for nanoscale therapeutics
Zhang, M., Cheng, S., Jin, Y., Zhang, N., & Wang, Y. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.292 · Cited by 158
Hide and Seek: Nanomaterial Interactions With the Immune System
Fadeel, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00133 · Cited by 157
“However, in the past few years, several studies on in vivo bio-corona formation have emerged, thus shedding light on the impact of the biocorona on NP clearance or targeting (58, 59), and its role for the toxicological outcomes of NP exposure (34, 60).”
BackgroundDesign and Development of Biomimetic Nanovesicles Using a Microfluidic Approach
Molinaro, R., Evangelopoulos, M., Hoffman, J. R., Corbo, C., Taraballi, F., Martinez, J. O., Hartman, K. A., Cosco, D., Costa, G., Romeo, I., et al. (2018) · Advanced Materials · doi:10.1002/adma.201702749 · Cited by 145
Self-citationSushnitha, M., Evangelopoulos, M., Tasciotti, E., & Taraballi, F. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00627 · Cited by 147
Self-citationAdvancing engineering design strategies for targeted cancer nanomedicine
Gomerdinger, V. F., Nabar, N., & Hammond, P. T. (2025) · Nature Reviews Cancer · doi:10.1038/s41568-025-00847-2 · Cited by 146
“Upon exposure to physiological fluid, nanoparticles develop a multilayered structure built from electrostatic and hydrophobic interactions among proteins and nano-particle cores 79,80 .”
Taraballi, F., Sushnitha, M., Tsao, C., Bauza, G., Liverani, C., Shi, A., & Tasciotti, E. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800490 · Cited by 129
Self-citationSingh, N., Marets, C., Boudon, J., Millot, N., Saviot, L., & Maurizi, L. (2021) · Nanoscale Advances · doi:10.1039/d0na00863j · Cited by 116
Stem cell membrane-coated abiotic nanomaterials for biomedical applications
Ferreira-Faria, I., Yousefiasl, S., Macário-Soares, A., Pereira-Silva, M., Peixoto, D., Zafar, H., Raza, F., Faneca, H., Veiga, F., Hamblin, M. R., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.012 · Cited by 117
Martinez, J. O., Molinaro, R., Hartman, K. A., Boada, C., Sukhovershin, R. A., Rosa, E. D., Kuri, D., Zhang, S., Evangelopoulos, M., Carter, A. M., et al. (2018) · Theranostics · doi:10.7150/thno.22078 · Cited by 122
“We demonstrated this decreased accumulation could be, in part, due to alterations in the protein corona that is formed around the leukosomes upon systemic administration [43] or the influence of the syngeneic nature of the membrane protein source [62].”
BackgroundSelf-citationDisease-specific protein corona sensor arrays may have disease detection capacity
Caracciolo, G., Safavi‐Sohi, R., Malekzadeh, R., Poustchi, H., Vasighi, M., Chiozzi, R. Z., Capriotti, A. L., Laganà, A., Hajipour, M. J., Domenico, M. D., et al. (2019) · Nanoscale Horizons · doi:10.1039/c9nh00097f · Cited by 115
Pinals, R. L., Chio, L., Ledesma, F., & Landry, M. P. (2020) · The Analyst · doi:10.1039/d0an00633e · Cited by 132
Bai, X., Wang, J., Mu, Q., & Su, G. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.646708 · Cited by 119
Li, Y., Liu, Y., Ren, Y., Su, L., Li, A., An, Y., Rotello, V. M., Zhang, Z., Wang, Y., Liu, Y., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004942 · Cited by 118
Nienhaus, K., Wang, H., & Nienhaus, G. U. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2019.100036 · Cited by 116
Exosome-like Nanovectors for Drug Delivery in Cancer
Arrighetti, N., Corbo, C., Evangelopoulos, M., Pastò, A., Zuco, V., & Tasciotti, E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867325666180831150259 · Cited by 101
Self-citationUnveiling the pitfalls of the protein corona of polymeric drug nanocarriers
Berrecoso, G., Crecente‐Campo, J., & Alonso, M. J. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00745-0 · Cited by 110
Chen, Y., Douanne, N., Wu, T.-C., Kaur, I., Tsering, T., Erzingatzian, A., Nadeau, A., Juncker, D., Nerguizian, V., & Burnier, J. V. (2025) · Science Advances · doi:10.1126/sciadv.ads5249 · Cited by 135
Papi, M., Caputo, D. D., Palmieri, V., Coppola, R., Palchetti, S., Bugli, F., Martini, C., Digiacomo, L., Pozzi, D., & Caracciolo, G. (2017) · Nanoscale · doi:10.1039/c7nr03042h · Cited by 102
Zou, D., Wu, Z., Yi, X., Hui, Y., Yang, G., Liu, Y., Tengjisi, Wang, H., Brooks, A., Wang, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214757120 · Cited by 104
“…on the soft MCSNs is attributable to the NP stiffness, suggesting its critical role in regulating the membrane coating process and consequently the final membrane protein compositions on the cell membrane-coated NPs. Protein corona plays a critical role in regulating nano–bio interactions (36, 37).”
Molinaro, R., Martinez, J. O., Zinger, A., De Vita, A., Storci, G., Arrighetti, N., De Rosa, E., Hartman, K. A., Basu, N., Taghipour, N., et al. (2020) · Biomaterials Science · doi:10.1039/c9bm01766f · Cited by 95
Self-citationThe impact of protein corona on the biological behavior of targeting nanomedicines
Farshbaf, M., Valizadeh, H., Panahi, Y., Fatahi, Y., Chen, M., Zarebkohan, A., & Gao, H. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121458 · Cited by 95
The Janus of Protein Corona on nanoparticles for tumor targeting, immunotherapy and diagnosis
Wang, X., & Zhang, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.056 · Cited by 86
Corbo, C., Cromer, W. E., Molinaro, R., Furman, N. E. T., Hartman, K. A., Rosa, E. D., Boada, C., Wang, X., Zawieja, D. C., Agostini, M., et al. (2017) · Nanoscale · doi:10.1039/c7nr04734g · Cited by 82
Self-citationBiomimetic Nanoparticles as a Theranostic Tool for Traumatic Brain Injury
Zinger, A., Soriano, S., Baudo, G., Rosa, E. D., Taraballi, F., & Villapol, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100722 · Cited by 78
Self-citationBioinspired metal–organic frameworks mediated efficient delivery of siRNA for cancer therapy
Zhang, Y., Yang, L., Wang, H., Huang, J., Lin, Y., Chen, S., Guan, X., Yi, M., Li, S., & Zhang, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131926 · Cited by 86
Arcella, A., Palchetti, S., Digiacomo, L., Pozzi, D., Capriotti, A. L., Frati, L., Oliva, M. A., Tsaouli, G., Rota, R., Screpanti, I., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00339 · Cited by 83
Zhao, Y., Zhuge, D., Tong, M., Lin, M., Zheng, Y., Jiang, X., Yang, W., Yao, Q., Xiang, Q., Li, X., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.034 · Cited by 75
Shao, M., Lopes, D., Lopes, J., Yousefiasl, S., Macário‐Soares, A., Peixoto, D., Ferreira-Faria, I., Veiga, F., Conde, J., Huang, Y., et al. (2023) · Matter · doi:10.1016/j.matt.2023.01.012 · Cited by 82
Synthetic cells in biomedical applications
Sato, W., Zajkowski, T., Moser, F., & Adamala, K. P. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1761 · Cited by 85
Unbiased Identification of the Liposome Protein Corona using Photoaffinity-based Chemoproteomics
Pattipeiluhu, R., Crielaard, S., Klein-Schiphorst, I., Florea, B. I., Kros, A., & Campbell, F. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01222 · Cited by 84
Wu, J., Li, Y., Wang, J., Hu, X.-B., Huang, S. Q., Luo, S., & Xiang, D. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01153-3 · Cited by 74
“The incubation time have impact on the proteins identified on the PC and longer incubation time may increase the number and enrichment of proteins [35, 44, 45].”
BackgroundMethodMetal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents
Shabatina, T. I., Vernaya, O. I., Shimanovskiy, N. L., & Melnikov, M. Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041181 · Cited by 82
Caracciolo, G., Palchetti, S., Digiacomo, L., Chiozzi, R. Z., Capriotti, A. L., Amenitsch, H. W., Tentori, P. M., Palmieri, V., Papi, M., Cardarelli, F., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04962 · Cited by 73
Nanoparticle protein corona evolution: from biological impact to biomarker discovery
Kamaly, N., Farokhzad, O. C., & Corbo, C. (2022) · Nanoscale · doi:10.1039/d1nr06580g · Cited by 67
Self-citationMolinaro, R., Pastò, A., Corbo, C., Taraballi, F., Giordano, F., Martinez, J. O., Zhao, P., Wang, X., Zinger, A., Boada, C., et al. (2019) · Nanoscale · doi:10.1039/c9nr04253a · Cited by 61
Self-citationCell membrane protein functionalization of nanoparticles as a new tumor‐targeting strategy
Pastò, A., Giordano, F., Evangelopoulos, M., Amadori, A., & Tasciotti, E. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0224-y · Cited by 56
“We studied in vivo the evolution of the PC over time and revealed that the integration of leukocyte membrane proteins into the leukosome bilayer influenced the number, amount, orientation and type of plasma proteins adsorbed by the NPs, thus affecting NP biodistribution and interaction with cells [56].”
BackgroundSelf-citationBiomimetic Nanocarriers for Cancer Target Therapy
Guido, C., Maiorano, G., Cortese, B., D’Amone, S., & Palamà, I. E. (2020) · Bioengineering · doi:10.3390/bioengineering7030111 · Cited by 63
“Furthermore, the role of biomimetic NPs to the reduction of systemic toxicity in drug delivery has been reported also by Corbo and co-workers [21] together with the promising biocompatibility and biosafety profiles reported by Evangelopoulos and colleagues that demonstrated a minimal accumulation of biomimetic NPs in…”
BackgroundOptically responsive delivery platforms: from the design considerations to biomedical applications
Koryakina, I., Kuznetsova, D. S., Zuev, D. A., Milichko, V. A., Timin, A. S., & Zyuzin, M. V. (2018) · Nanophotonics · doi:10.1515/nanoph-2019-0423 · Cited by 54
Principal component analysis of personalized biomolecular corona data for early disease detection
Papi, M., & Caracciolo, G. (2018) · Nano Today · doi:10.1016/j.nantod.2018.03.001 · Cited by 53
Biomimetic Nanovesicles—Sources, Design, Production Methods, and Applications
Mougenot, M. F., Pereira, V. S., Costa, A. L. R., Lancellotti, M., Porcionatto, M. A., da Silveira, J. C., & de la Torre, L. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102008 · Cited by 67
“According to the authors, this surface modification may function as leukocyte receptors favoring the iteration, with immunoglobin G (IGg) antibody and protein receptors not being able to bind their receptors to those of macrophages, which is what happens to liposomes without modifications [61].”
BackgroundLi, Z., Wang, Y., Zhu, J., Zhang, Y., Zhang, W., Zhou, M., Luo, C., Li, Z. J., Cai, B., Gui, S., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.007 · Cited by 51
Feng, R., Yu, F., Xu, J., & Hu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120469 · Cited by 55
Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy
Fan, L., Wei, A., Gao, Z., & Mu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114451 · Cited by 57
Corbo, C., Li, A. A., Poustchi, H., Lee, G. Y., Stacks, S., Molinaro, R., Ma, P., Platt, T., Behzadi, S., Langer, R., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000948 · Cited by 51
Self-citationUnderstanding and utilizing the biomolecule/nanosystems interface
Chen, E. Y., Liu, W. F., Megido, L., Díez, P., Fuentes, M., Fager, C., Olsson, E., Gessner, I., & Mathur, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48063-5.00003-4 · Cited by 62
Protein corona: challenges and opportunities for targeted delivery of nanomedicines
Jiang, Z., Chu, Y., & Zhan, C. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2093854 · Cited by 47
Ren, N., Liang, N., Dong, M., Feng, Z., Meng, L., Sun, C., Wang, A., Yu, X., Wang, W., Xie, J., et al. (2022) · Small · doi:10.1002/smll.202202485 · Cited by 44
Biomimetic erythrocytes engineered drug delivery for cancer therapy
Zhang, W., Zhao, M., Gao, Y., Xu, C., Liu, X., Tang, S., Peng, Y., Wang, N., Hu, D., Peng, H., et al. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.133498 · Cited by 46
Harnessing Protein Corona for Biomimetic Nanomedicine Design
Chen, Z., Chen, X., Huang, J., Wang, J., & Wang, Z. (2022) · Biomimetics · doi:10.3390/biomimetics7030126 · Cited by 50
“, fabricated biomimetic liposomes with WBC membranes called leukosomes, and this system showed a gorgeous ability to target inflamed endothelium and avoid clearance by the immune system [73].”
BackgroundInfluentialGrundler, J., Shin, K., Suh, H., Whang, C., Fulgoni, G., Pierce, R. W., & Saltzman, W. M. (2024) · ACS Nano · doi:10.1021/acsnano.3c05921 · Cited by 47
Nanoparticles target early-stage breast cancer metastasisin vivo
Goldman, E., Zinger, A., da Silva, D., Yaari, Z. A., Kajal, A., Vardi‐Oknin, D., Goldfeder, M., Schroeder, J. E., Shainsky‐Roitman, J., Hershkovitz, D., et al. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa8a3d · Cited by 43
“PEG conjugated to the corona of the liposomes extends the liposomes’ circulation time in vivo [86], and their nano-dimensions facilitates extravasation through the compromised tumor vasculature [87, 88].”
BackgroundImplications of biomimetic nanocarriers in targeted drug delivery
Al‐Hetty, H. R. A. K., Kadhim, M. S., Al-Tamimi, J. H. Z., Ahmed, N. M., Jalil, A. T., Saleh, M. M., Kandeel, M. K., & Abbas, R. H. (2023) · Emergent Materials · doi:10.1007/s42247-023-00453-8 · Cited by 46
Molinaro, R., Pastò, A., Taraballi, F., Giordano, F., Azzi, J. A., Tasciotti, E., & Corbo, C. (2020) · Nanomaterials · doi:10.3390/nano10112301 · Cited by 41
“Our group has recently developed leukocyte-inspired nanovesicles, called leukosomes, which, by mimicking real cells, avoid rapid clearance by the mononuclear phagocytic system and target the inflamed endothelium [11,15,16].”
BackgroundSelf-citationPerformance of nanoparticles for biomedical applications: The in vitro / in vivo discrepancy
Berger, S., Berger, M., Bantz, C., Maskos, M., & Wagner, E. (2022) · Biophysics Reviews · doi:10.1063/5.0073494 · Cited by 46
Liposome protein corona characterization as a new approach in nanomedicine
Capriotti, A. L., Cavaliere, C., & Piovesana, S. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01656-x · Cited by 38
Biohybrid Nanoparticles to Negotiate with Biological Barriers
Mohammadi, M. R., Corbo, C., Molinaro, R., & Lakey, J. R. T. (2019) · Small · doi:10.1002/smll.201902333 · Cited by 38
Self-citationPhosphoprotein-based biomarkers as predictors for cancer therapy
Carter, A. M., Tan, C., Pozo, K., Telange, R., Molinaro, R., Guo, A., Rosa, E. D., Martinez, J. O., Zhang, S., Kumar, N., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010103117 · Cited by 37
Self-citationInfluence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions
Fontana, F., Lindstedt, H., Correia, A., Chiaro, J., Kari, O. K., Ndika, J., Alenius, H. T., Buck, J., Sieber, S., Mäkilä, E. M., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000529 · Cited by 41
Bao, J., Zhang, Q., Duan, T., Hu, R., & Tang, J. (2021) · Current Drug Targets · doi:10.2174/1389450122666210118105122 · Cited by 38
Kristensen, K., Münter, R., Kempen, P., Thomsen, M., Stensballe, A., & Andresen, T. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.008 · Cited by 33
Lu, M., Zhao, X., Xing, H., Xun, Z., Yang, T., Cai, C., Wang, D., & Ding, P. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.043 · Cited by 33
Li, M., Guo, Q., Zhong, C., & Zhang, Z. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2288797 · Cited by 37
Cell Membrane‐Coated Lipid Nanoparticles for Drug Delivery
Zewail, M. B., Yang, G., Fan, Y., Hui, Y., Zhao, C., & Liu, Y. (2025) · Aggregate · doi:10.1002/agt2.70054 · Cited by 52
“For more detailed profiling, mass spectrometry-based proteomics is employed following tryptic digestion of SDS-PAGE-resolved bands [201, 205].”
InfluentialCamouflaging Nanoparticles for Ratiometric Delivery of Therapeutic Combinations
Meng, F., Wang, J., Ping, Q., & Yeo, Y. (2019) · Nano Letters · doi:10.1021/acs.nanolett.8b04017 · Cited by 32
Biomimetic nano drug delivery carriers for treating cardiovascular diseases
Zinger, A., Cooke, J. P., & Taraballi, F. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102360 · Cited by 36
Self-citationCancer: Nanoscience and Nanotechnology Approaches
Chan, W. C. W., Khademhosseini, A., Parak, W. J., & Weiss, P. S. (2017) · ACS Nano · doi:10.1021/acsnano.7b03308 · Cited by 31
COVID-19 inflammation and implications in drug delivery
Zoulikha, M., Huang, F., Wu, Z., & He, W. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.04.027 · Cited by 32
“Although both NPs have been opsonized by the same proteins (mainly IgG, coagulation and complement factors), revealed by an increase of their diameter from ~170 nm before in vivo administration to ~350 nm 1h post-injection, biomimetic NPs were less taken up by macrophages [125].”
BackgroundTracing the In Vivo Fate of Nanoparticles with a “Non-Self” Biological Identity
Mohammad‐Beigi, H., Scavenius, C., Jensen, P. B., Kjær-Sørensen, K., Oxvig, C., Boesen, T. P., Enghild, J. J., Sutherland, D. S., & Hayashi, Y. (2020) · ACS Nano · doi:10.1021/acsnano.0c05178 · Cited by 27
Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis
Guo, X., Lou, J. N., Wang, F., Fan, D., & Qin, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924387 · Cited by 28
Tiboni, M., Coppari, S., Casettari, L., Guescini, M., Colomba, M., Fraternale, D., Gorassini, A., Verardo, G., Ramakrishna, S., Guidi, L., et al. (2020) · Nanomaterials · doi:10.3390/nano11010036 · Cited by 25
“Phenolic compounds contained in the PSF extract demonstrated different nutraceutical effects such as antioxidant and anti-inflammatory activities [35] that can be enhanced when paired with the active targeting to inflamed endothelium, as carefully characterized in previous works [21,36].”
Self-citationNanoparticle–proteome in vitro and in vivo
Wang, M., Gustafsson, O., Pilkington, E. H., Käkinen, A., Javed, I., Faridi, A., Davis, T. P., & Ke, P. C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01634h · Cited by 25
“…ein A-I Ig kappa chain C Ig kappa chain C Putative uncharacter ized protein Hemoglobi n subunit beta-2 Fibrinogen gamma chain In vivo (2) Literature Corbo et al (2017) (in vivo only) Zhu et al (2017) (in vitro vs in vivo) Bertrand et al (2017) (in vivo only) Nanoparticl e core Liposome Leukosome…”
BackgroundThe Competitive Dynamic Binding of Some Blood Proteins Adsorbed on Gold Nanoparticles
Zhang, X., Shi, H., Zhang, R., Zhang, J., Xu, F., Qiao, L., & Yu, S. (2018) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201800257 · Cited by 24
Nanoparticle behavior and stability in biological environments
Martínez, R., Poupard, M. F. N., Álvarez, A., Soprano, E., Migliavacca, M., Carrillo‐Carrión, C., Polo, E., Pelaz, B., & del Pino, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816662-8.00002-3 · Cited by 33
Jaiswal, N., Halder, S., Mahata, N., & Chanda, N. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01216 · Cited by 23
Protein adsorption onto nanomaterials engineered for theranostic applications
Nienhaus, K., Xue, Y., Shang, L., & Nienhaus, G. U. (2022) · Nanotechnology · doi:10.1088/1361-6528/ac5e6c · Cited by 24
“In vivo experiments monitoring NM structure and dynamics are extremely challenging and thus still scarce [ 213, 214 ] .”
Protein corona in vivo: dynamic complement proteins-mediated opsonization and immune modulation
Cai, R., & Chen, C. (2017) · 中国科学通报:英文版 · doi:10.1016/j.scib.2017.07.002 · Cited by 20
“Recently, another study has demonstrated that protein coronas formed on intravenously injected liposomes in vivo are different in composition compared with the protein coronas formed ex vivo [7].”
BackgroundQu, H., Jin, X., Cheng, W., Wu, D., Ma, B., Lou, C., Zheng, J., Jing, L., Xue, X., & Wang, Y. (2023) · Particle and Fibre Toxicology · doi:10.1186/s12989-023-00529-7 · Cited by 22
“The protein corona-mediated opsonin effect is one of the main factors that can affect the biodistribution of NPs [27, 30].”
BackgroundSurface roughness effect on the cellular uptake of layered double hydroxide nanoparticles
Kim, H.-J., Kim, S. H., Kim, H., Kim, Y. S., & Oh, J. (2021) · Applied Clay Science · doi:10.1016/j.clay.2021.105992 · Cited by 19
Evolution of the protein corona affects macrophage polarization
Yang, H., Lu, S., Wang, S., Liu, L., Zhu, B., Yu, S., Yang, S., & Chang, J. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.081 · Cited by 18
Hybrid Clustered Nanoparticles for Chemo-Antibacterial Combinatorial Cancer Therapy
Cortese, B., D’Amone, S., Testini, M., Ratano, P., & Palamà, I. E. (2019) · Cancers · doi:10.3390/cancers11091338 · Cited by 18
“It is reported that a low quantity of proteins that form the protein corona around nanoparticles induce a reduction of macrophages uptake [34].”
BackgroundThe influence of protein corona on liposomal delivery systems: A comprehensive review
Mojarad-Jabali, S., Fatahi, Y., & Dinarvand, R. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107166 · Cited by 20
Understanding the Mechanism of Cardiotoxicity Induced by Nanomaterials: A Comprehensive Review
Zheng, Z., Zhu, S., Wang, X., Wu, H., Fu, M., Hu, H., Gu, Z., & Zhang, C. (2025) · Small Science · doi:10.1002/smsc.202400498 · Cited by 22
Wang, F., Deng, Y., Yu, L., Zhou, A., Wang, J., Jia, J., Li, N., Ding, F., Lian, W., Liu, Q., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112341 · Cited by 17
“After an intravenous administration, it was reported that the macrophage membrane surface may endow the nanoparticles with less plasma protein absorption and active trans-endothelium capability to pass through the vasculature in the inflamed sites [67,68].”
BackgroundUnravelling the role of lipid composition on liposome-protein interactions
Nele, V., D’Aria, F., Campani, V., Silvestri, T., Biondi, M., Giancola, C., & Rosa, G. D. (2023) · Journal of Liposome Research · doi:10.1080/08982104.2023.2224449 · Cited by 16
“Alternative approaches to prevent opsonisation and enhance the half-life in circulation entail coating the nanoparticle surface with cell membranes derived from e.g. red blood cells (Ferrel et al. 2021) and leukocytes (Corbo et al. 2017) or with human plasma proteins (Giulimondi et al. 2019).”
BackgroundNanodelivery Systems Face Challenges and Limitations in Bone Diseases Management
Giordano, F., Lenna, S., Rampado, R., Brozovich, A., Hirase, T., Tognon, M. G., Martini, F., Agostini, M., Yustein, J. T., & Taraballi, F. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100152 · Cited by 23
Self-citation
Metadata
- Authors
- Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E.
- Affiliations
- CEINGE Biotecnologie Avanzate Franco Salvatore (Italy) (IT)
- Houston Methodist (US)
- The University of Texas Medical Branch at Galveston (US)
- Corresponding author
- Corbo, Claudia
- Tasciotti, Ennio
- ORCID
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-03-10
- Volume
- 11
- Issue
- 3
- Pages
- 3262-3273
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2592013183
- Cited by
- 155
- References
- 53
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 5 · 2023: 22 · 2022: 20 · 2021: 17 · 2020: 26 · 2019: 17 · 2018: 16 · 2017: 7
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Funders
- European Regional Development Fund
- Hearst Foundations (18130017)
- Ministero della Salute (RF-2010-2305526, RF-2010-2318372)
- Cancer Prevention and Research Institute of Texas (RP170466)
- European Social Fund
- Brown Foundation (18130011)
- Regione Campania
- Cullen Trust for Healthcare (18130014)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- protein corona, biomimetic liposomes, nanoparticle-biomolecule interactions, macrophage receptors, nanoparticle biodistribution, nanoparticle pharmacokinetics, nanomedicine
- MeSH terms
- Protein Corona, Adsorption, Animals, Cell Line, Liposomes, Mass Spectrometry, Microscopy, Confocal, Electrophoresis, Capillary, Cryoelectron Microscopy, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.